CompletedNCT00290121
Brain activity and appetite in schizophrenia during antipsychotic treatment
About this title
Read the official source — NCT00290121Medication studyAges 18–60Canada
Understand this study
Who was this study for?
Listed age limits: 18 years to 60 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
Study information
Study start dateSeptember 2006
- Recruitment status
- Completed
- Enrollment listed in the registry
- 25
- Sponsor
- Université de Montréal
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 4Usually happens after approval, to monitor real-world use, safety, and longer-term outcomes.
- Locations
- Canada
- Age range
- From 18 Years to 60 Years
- Official registry ID
- NCT00290121
- Official title
Show the full official title
Cerebral Mechanism Involved in Appetite Increase in Schizophrenia Patients Treated With Atypical Antipsychotics (IIT)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Questions about this study
Who is behind this study?
The study sponsor is Université de Montréal, a university.
Did this study involve medication?
Yes. The study involved medication, including Olanzapine.
Who was this study for?
Listed age limits: 18 years to 60 years.
